These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 19692415)

  • 1. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.
    Meijers BK; De Preter V; Verbeke K; Vanrenterghem Y; Evenepoel P
    Nephrol Dial Transplant; 2010 Jan; 25(1):219-24. PubMed ID: 19692415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
    Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease.
    Melekoglu E; Cetinkaya MA; Kepekci-Tekkeli SE; Kul O; Samur G
    PLoS One; 2021; 16(10):e0258145. PubMed ID: 34614017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of protein-bound uraemic toxins by haemodialysis.
    Niwa T
    Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate.
    Viaene L; Annaert P; de Loor H; Poesen R; Evenepoel P; Meijers B
    Biopharm Drug Dispos; 2013 Apr; 34(3):165-75. PubMed ID: 23300093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
    Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.
    Poesen R; Viaene L; Verbeke K; Claes K; Bammens B; Sprangers B; Naesens M; Vanrenterghem Y; Kuypers D; Evenepoel P; Meijers B
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1508-14. PubMed ID: 23813557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography.
    de Loor H; Meijers BK; Meyer TW; Bammens B; Verbeke K; Dehaen W; Evenepoel P
    J Chromatogr A; 2009 May; 1216(22):4684-8. PubMed ID: 19394619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study.
    Wu IW; Hsu KH; Hsu HJ; Lee CC; Sun CY; Tsai CJ; Wu MS
    Nephrol Dial Transplant; 2012 Mar; 27(3):1169-75. PubMed ID: 21891772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
    Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
    Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
    Lin CJ; Wu V; Wu PC; Wu CJ
    PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
    Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
    Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.
    Yamamoto S; Kazama JJ; Omori K; Matsuo K; Takahashi Y; Kawamura K; Matsuto T; Watanabe H; Maruyama T; Narita I
    Sci Rep; 2015 Sep; 5():14381. PubMed ID: 26395517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heritability and clinical determinants of serum indoxyl sulfate and p-cresyl sulfate, candidate biomarkers of the human microbiome enterotype.
    Viaene L; Thijs L; Jin Y; Liu Y; Gu Y; Meijers B; Claes K; Staessen J; Evenepoel P
    PLoS One; 2014; 9(5):e79682. PubMed ID: 24850265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Poesen R; Evenepoel P; de Loor H; Delcour JA; Courtin CM; Kuypers D; Augustijns P; Verbeke K; Meijers B
    PLoS One; 2016; 11(4):e0153893. PubMed ID: 27100399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis.
    Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
    Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
    Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.
    Viaene L; Meijers BK; Bammens B; Vanrenterghem Y; Evenepoel P
    Perit Dial Int; 2014; 34(1):71-8. PubMed ID: 24179107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients.
    Lin CJ; Wu CJ; Pan CF; Chen YC; Sun FJ; Chen HH
    Nephrol Dial Transplant; 2010 Nov; 25(11):3693-700. PubMed ID: 20466687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.